- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medrad launches prostate education
Medrad unveiled an educational program at the ISMRM meeting designed to teach the operators of GE Signa scanners how to perform prostate MR with its eCoil Endorectal Coil.
Medrad unveiled an educational program at the ISMRM meeting designed to teach the operators of GE Signa scanners how to perform prostate MR with its eCoil Endorectal Coil.
The correspondence program will be led by John Kurhanewicz, Ph.D., director of the Prostate Cancer Imaging Research Program at the University of California, San Francisco and Dr. Nicolas Bloch, radiology clinician researcher at Beth Israel Deaconess Medical Center.
Clinicians will have up to six hours of e-mail, telephone, video conference, and/or instant message access to the expert physicians, according to the Bayer affiliate. Kurhanewicz and Bloch have a combined 22 years of experience in this specialty, having performed more than 7000 prostate MR imaging procedures.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
